Activest Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Activest Wealth Management’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$31.9K	Hold	759	–	–	0.01%	348
2026 Q1	$20.1K	Hold	759	–	–	﹤0.01%	524
2025 Q4	$22K	Hold	759	–	–	﹤0.01%	485
2025 Q3	$21.1K	Hold	759	–	–	﹤0.01%	372
2025 Q2	$18.5K	Sell	759 -260	-26%	-$5.7K	﹤0.01%	336
2025 Q1	$21.2K	Buy	1,019 +113	+12%	+$2.84K	0.01%	288
2024 Q4	$21.3K	Hold	906	–	–	0.01%	243
2024 Q3	$23.2K	Sell	906 -6,647	-88%	-$169K	0.01%	238
2024 Q2	$177K	Buy	7,553 +7,338	+3,413%	+$185K	0.06%	89
2024 Q1	$6.18K	Buy	215 +190	+760%	+$5.71K	﹤0.01%	244
2023 Q4	$820	Hold	25	–	–	﹤0.01%	293
2023 Q3	$697	Buy	+25	New	+$817	﹤0.01%	307
2023 Q2	–	Sell	-25	Closed	-$717	–	299
2023 Q1	$717	Sell	25 -1,633	-98%	-$50.6K	﹤0.01%	291
2022 Q4	$48K	Hold	1,658	–	–	0.01%	188
2022 Q3	$57K	Buy	1,658 +1,633	+6,532%	+$60K	0.02%	170
2022 Q2	$1K	Hold	25	–	–	﹤0.01%	350
2022 Q1	$1K	Sell	25 -2,735	-99%	-$130K	﹤0.01%	308
2021 Q4	$169K	Buy	2,760 +921	+50%	+$63.7K	0.1%	59
2021 Q3	$137K	Hold	1,839	–	–	0.09%	59
2021 Q2	$170K	Sell	1,839 -2,489	-58%	-$212K	0.13%	54
2021 Q1	$384K	Buy	+4,328	New	+$429K	0.31%	37

Other funds holding ARKG

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Activest Wealth Management's ARKG Position: Q2 2026 in Review

Activest Wealth Management held its ARK Genomic Revolution ETF (ARKG) position steady in Q2 2026 at 759 shares worth $31.9K. The position accounts for 0.01% of the portfolio, ranked #348.

Activest Wealth Management first reported a position in ARKG in Q1 2021 and has held it in 21 quarters since. The position peaked at $384K in Q1 2021. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

Activest Wealth Management held 759 shares of ARK Genomic Revolution ETF worth $31.9K as of Q2 2026.
Activest Wealth Management left its ARK Genomic Revolution ETF share count unchanged in Q2 2026.
ARK Genomic Revolution ETF made up 0.01% of Activest Wealth Management's portfolio in Q2 2026, its #348 holding.
Activest Wealth Management first reported a position in ARK Genomic Revolution ETF in Q1 2021 and has held it in 21 quarters since.
Activest Wealth Management's ARK Genomic Revolution ETF position peaked at $384K in Q1 2021.
271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Activest Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.